AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $234,000 | -10.7% | 6,800 | -62.6% | 0.32% | +133.8% |
| Q1 2020 | $262,000 | -57.0% | 18,200 | 0.0% | 0.14% | +95.8% |
| Q4 2019 | $609,000 | -89.3% | 18,200 | -91.3% | 0.07% | -78.2% |
| Q3 2018 | $5,701,000 | -8.7% | 209,000 | -10.0% | 0.33% | -10.9% |
| Q2 2018 | $6,246,000 | +3.7% | 232,300 | +22.7% | 0.37% | -4.9% |
| Q1 2018 | $6,025,000 | – | 189,300 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|